Finasteride + Oral Minoxidil: Evidence, Dosing & Comparison
Medically reviewed by [Reviewer Name, MD] | Last reviewed: August 2026 | Editorial policy
Oral minoxidil is a systemic formulation of the same molecule used in topical hair-loss products. At low doses (1.25–5 mg/day), it produces hair regrowth via vasodilation and potassium channel opening — complementary to finasteride’s DHT-blocking mechanism. Combining the two is an increasingly common regimen in dermatology practice.
Oral vs. Topical Minoxidil: Key Differences
| Property | Topical Minoxidil (2% / 5%) | Oral Minoxidil (2.5–5 mg) |
|---|---|---|
| FDA approval (AGA) | Yes (men 5%, women 2%) | No (off-label for AGA) |
| Route | Applied to scalp once or twice daily | Oral tablet once daily |
| Systemic absorption | ~1–2% | 100% |
| Efficacy for AGA | Established | Growing evidence; likely superior to topical at equivalent doses |
| Side effect: fluid retention | Very rare | Dose-dependent; possible at ≥2.5 mg |
| Side effect: unwanted body hair | Rare | More common (hypertrichosis) |
| Cardiac risk | Minimal | Small BP reduction; caution in cardiovascular disease |
Evidence for the Combination
Vañó-Galván et al. (2022) published a multicenter retrospective study of 1,404 patients treated with low-dose oral minoxidil for AGA; Randolph et al. (2021) reviewed dermatologist prescribing patterns showing rapid adoption. Dedicated finasteride + oral minoxidil combination RCT data are limited, but mechanistic complementarity is well-established and the combination is increasingly recommended in trichology and dermatology guidelines.
- Typical combination: finasteride 1 mg/day + oral minoxidil 2.5 mg/day
- Adding a low-dose diuretic (e.g. spironolactone 25 mg) may offset fluid retention at higher oral minoxidil doses — discuss with prescriber
- Cardiovascular pre-screening is appropriate before starting oral minoxidil in men over 40 or those with cardiac history
See also: Finasteride + topical minoxidil combination | Finasteride vs. minoxidil
Sources
- Vañó-Galván S, et al. “Expanded indications of low-dose oral minoxidil as a treatment for alopecia.” J Am Acad Dermatol. 2022;87(4):884–886.
- Randolph M & Tosti A. “Oral minoxidil treatment for hair loss: a review of efficacy and safety.” J Am Acad Dermatol. 2021;84(3):737–746.